Utilization, Workflow, and Outcomes of Endovascular Thrombectomy in Patients With vs Without Premorbid Disability in a National Registry

Background and Objectives Given the paucity of high-quality safety/efficacy data on acute stroke therapies in patients with premorbid disability, they risk being routinely excluded from such therapies. We examined utilization of endovascular thrombectomy (EVT), associated workflow, and poststroke outcomes among patients with vs without premorbid disability. Methods We used national registry data on thrombolysis/EVT for the Czech Republic from 1 January 2016 to 31 December 2020. Premorbid disability was defined as prestroke modified Rankin Scale score (mRS) ≥3. We compared proportions of patients with vs without premorbid disability who received EVT and examined workflow times. We compared DmRS—change in mRS from prestroke to 3 months—in patients with vs without premorbid disability, in addition to intracerebral hemorrhage (ICH), mortality, and discharge NIHSS (National Institutes of Health Stroke Scale score), adjusting for age, sex, baseline NIHSS, and comorbidities, and verified using propensity score weighting (PSW) and matching for differences in treatment assignment. We stratified by age group (<65, 65–74, 75–84, ≥85 years) to explore outcome heterogeneity with vs without premorbid disability. Results Among 22,405 patients with ischemic stroke who received thrombolysis/EVT/both, 1,712 (7.6%) had prestroke mRS ≥ 3. Patients with prestroke disability were less likely to receive EVT vs those without (10.1% vs 20.7%, aOR: 0.30, 95% CI 0.24–0.36). When treated, they had longer door-to-arterial puncture times (median: 75 minutes, IQR: 58–100 vs 54, IQR: 27–77, adjusted difference: 12.5, 95% CI 2.68–22.3). Patients with prestroke disability receiving thrombolysis/EVT/both had worse DmRS (adjusted rate ratio, aIRR on PSW: 1.57, 95% CI 1.43–1.72), rates of 3-month mRS 5–6, discharge NIHSS, and mortality (aOR-PSW [mortality]: 2.54, 95% CI 1.92–3.34), while ICH did not significantly differ. 32.1% of patients with prestroke disability receiving thrombolysis/EVT/both successfully returned to prestroke state, but this proportion ranged from 19.6% for those older than 85 years to 66.0% for those younger than 65 years. Regardless of premorbid disability, EVT was associated with better outcomes including lower DmRS (aIRR-PSW: 0.87, 95% CI 0.83–0.91) and mortality, with no interaction of treatment effect by premorbid disability status (e.g., mortality p_interaction = 0.73). EVT recipients with premorbid disability did not differ significantly for several outcomes including DmRS (aIRR: 0.99, 95% CI 0.84–1.17) but were more likely to have 3-month mRS 5–6 (70.1% vs 39.5% without premorbid disability, aOR: 1.85, 95% CI 1.12–3.04). Discussion Patients with premorbid disability were less likely to receive EVT, had slower treatment times, and had worse outcomes compared with patients without premorbid disability. However, regardless of premorbid disability, patients fared better with EVT vs medical management and one-third with prestroke disability returned to their prestroke status.